Predicting Treatment Response to a Rapid Antidepressant

Brain activity during specific tasks may predict how well patients with major depressive disorder respond to the experimental antidepressant scopolamine. The finding suggests that brain imaging might help identify good candidates for the treatment.

Depression is thought to be caused by a complex combination of genetic, biological, environmental and psychological factors. People with major depression have feelings of sadness, loss, anger or frustration that interfere with daily life for weeks or longer. Symptoms can also include memory loss and trouble focusing.

A variety of antidepressants that target chemicals in the brain are used to treat major depression. Unfortunately, antidepressants must typically be taken for several weeks before working, and some may not work well in certain people. Patients may need to try several treatments over many weeks before finally getting symptom relief.

Dr. Maura Furey and colleagues at NIH’s National Institute of Mental Health (NIMH) have been studying scopolamine, a drug commonly used to treat motion sickness. The researchers discovered in 2006 that it can also improve depression in just a few days. Although fast-acting, scopolamine isn’t effective in all patients.

To develop a way to predict the drug’s effects in advance, the researchers studied 36 adults (ages 18 to 55), 15 with major depression and 21 without. The participants underwent functional MRI (fMRI) to measure brain activity as they completed tasks that involved processing visual information. When asked to pay attention to different aspects of images that show emotion, people with major depression have unique patterns of brain activity. The study was designed based on the idea that depressed patients tend to have a processing bias—they process and remember negative emotional information (such as sadness) more than positive (happy) or neutral information.


 Get The Latest By Email

Weekly Magazine Daily Inspiration

For some trials, participants were asked to pay attention to, and remember, the emotional expression of faces flashing on a computer monitor. For other trials, they were asked to pay attention only to the identity, or non-emotional features, of the faces. After scanning, and over the following several weeks, the participants randomly received infusions of scopolamine or a placebo saline solution. Their mood changes were monitored with depression rating scales.

that 11 of 15 participants with major depression had a significant decrease in depression symptoms in response to scopolamine treatment. The effectiveness of the treatment correlated with brain activity during the task only when patents were paying attention to emotion features. The correlation was found in a brain area known as the bilateral middle occipital cortex. In addition, brain activity in the same region was altered within just a few hours after infusion of scopolamine—well before any antidepressant effects. Activity in this region might thus serve as a biomarker to inform treatment strategies.

These findings suggest that visual processing may play a role in depression. They also show that monitoring areas of the brain that respond to emotional stimuli might be a feasible way to guide treatments for major depression.

We have discovered a potential neuroimaging biomarker that may eventually help to personalize treatment selection by revealing brain-based differences between patients,” Furey says.

Article Source: NIH Research Matters

AVAILABLE LANGUAGES

English Afrikaans Arabic Chinese (Simplified) Chinese (Traditional) Danish Dutch Filipino Finnish French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Malay Norwegian Persian Polish Portuguese Romanian Russian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese

follow InnerSelf on

facebook icontwitter iconyoutube iconinstagram iconpintrest iconrss icon

 Get The Latest By Email

Weekly Magazine Daily Inspiration

Saturday, 08 May 2021 08:43

Humanity has always had a rocky relationship with wasps. They are one of those insects that we love to hate. We value bees (which also sting) because they pollinate our crops and make honey

Friday, 28 July 2023 17:45

Respiratory viruses like influenza virus (flu), SARS-CoV-2 (which causes COVID) and respiratory syncytial virus (RSV) can make us sick by infecting our respiratory system, including the nose, upper...

Tuesday, 18 May 2021 16:15

In my blog posts, free resources, and courses, I talk a lot about the things that we can do to support and develop our inborn, natural interspecies communication abilities. In this post, I...

Wednesday, 05 May 2021 08:15

While our immune system and antibiotics both do a great job of helping us fight life-threatening infections, the emergence of antibiotic resistance is quickly making it more difficult to cure...

Tuesday, 04 May 2021 08:32

Cognitive motor training helps in the fight against Alzheimer’s and dementia, according to new research.

Monday, 24 July 2023 19:42

Today, mountains of calorie-rich (and often nutritionally poor) food and lakes of sugary beverages are readily available in much of the world. It’s no longer necessary to leave home — or even stand...

New Attitudes - New Possibilities

InnerSelf.comClimateImpactNews.com | InnerPower.net
MightyNatural.com | WholisticPolitics.com | InnerSelf Market
Copyright ©1985 - 2021 InnerSelf Publications. All Rights Reserved.